Efficacy and safety of vixotrigine in idiopathic or diabetes-associated painful small fibre neuropathy (CONVEY): a phase 2 placebo-controlled enriched-enrolment randomised withdrawal study

eClinicalMedicine（2023）

引用 3|浏览11

暂无评分

摘要

Biogen, Inc.

查看译文

关键词

vixotrigine,painful small fibre,diabetes-associated,placebo-controlled,enriched-enrolment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要